Showing results (141-150 of 172) with videos related to
Sort By:
Pageof 18
Blood|January 12, 2012
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)Oliver C Goodyear, Mike Dennis, Nadira Y Jilani, et al.Vaccines|April 30, 2021
Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected AdultsMichael Riste, Julia L Marshall, Iman Satti, et al.Plos One|November 4, 2015
A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy AdultsSharon Sheehan, Stephanie A Harris, Iman Satti, et al.Communications Biology|January 3, 2026
Endemic penetrance of SARS-CoV-2 has impacted marginally on immunity to spike protein of human coronavirusesTara Lancaster, Gokhan Tut, Panagiota Sylla, et al.The Lancet. Healthy Longevity|August 25, 2021
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational studyGokhan Tut, Tara Lancaster, Maria Krutikov, et al.Journal of Hematology & Oncology|January 10, 2022
Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemiaHelen Parry, Graham McIlroy, Rachel Bruton, et al.Scientific Reports|June 27, 2026
The impact of ethnicity on longitudinal humoral and cellular immune responses to SARS-CoV-2 booster vaccinationChristopher A Martin, Joshua Nazareth, Lucy Teece, et al.The Journal of Infectious Diseases|April 16, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI)Oliver Stirrup, Maria Krutikov, Gokhan Tut, et al.The Lancet. Healthy Longevity|July 11, 2022
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort studyGokhan Tut, Tara Lancaster, Panagiota Sylla, et al.Nature Immunology|March 6, 2021
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Alexander C Dowell, Hayden Pearce, et al.Pageof 18